Astera Labs (NASDAQ:ALAB) Shares Down 5.3% – What’s Next?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) fell 5.3% on Thursday . The stock traded as low as $280.53 and last traded at $284.53. 3,187,307 shares were traded during trading, a decline of 40% from the average session volume of 5,292,045 shares. The stock had previously closed at $300.54.

Analysts Set New Price Targets

A number of research firms have recently weighed in on ALAB. Royal Bank Of Canada lifted their target price on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a research note on Monday, August 17th. UBS Group reaffirmed a “neutral” rating and set a $425.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Needham & Company LLC lifted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Finally, Jefferies Financial Group boosted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Stock Performance

The stock has a market capitalization of $50.52 billion, a price-to-earnings ratio of 144.17 and a beta of 3.77. The company has a fifty day simple moving average of $316.60 and a two-hundred day simple moving average of $260.17.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the sale, the director directly owned 3,970 shares of the company’s stock, valued at approximately $1,237,965.10. This trade represents a 69.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 592,244 shares of company stock worth $209,729,973. 10.40% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the stock. Capstone Financial Advisors Inc. acquired a new position in Astera Labs during the 2nd quarter worth about $274,000. Sequoia Financial Advisors LLC raised its position in shares of Astera Labs by 19.0% during the second quarter. Sequoia Financial Advisors LLC now owns 3,677 shares of the company’s stock worth $1,776,000 after acquiring an additional 588 shares during the last quarter. Archford Capital Strategies LLC acquired a new position in shares of Astera Labs in the second quarter worth approximately $506,000. Integrated Wealth Concepts LLC lifted its stake in shares of Astera Labs by 0.7% in the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock worth $3,384,000 after acquiring an additional 52 shares during the period. Finally, IFP Advisors Inc boosted its holdings in Astera Labs by 9.2% in the second quarter. IFP Advisors Inc now owns 4,241 shares of the company’s stock valued at $2,048,000 after acquiring an additional 356 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.